Страна: Австралия
Език: английски
Източник: Department of Health (Therapeutic Goods Administration)
betahistine dihydrochloride, Quantity: 24 mg
Southern XP IP Pty Ltd
betahistine dihydrochloride
Tablet
Excipient Ingredients: lactose monohydrate; maize starch; microcrystalline cellulose; citric acid; povidone; crospovidone; hydrogenated vegetable oil
Oral
25
(S4) Prescription Only Medicine
Meniere's syndrome as defined by the following core symptoms: vertigo (with nausea/ vomiting); hearing loss (hardness of hearing); tinnitus.
Visual Identification: White flat tablets with bevelled edges and a break line on one side; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
2017-03-02